| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2026-04-30 | 1,048.55 | 1,051.95 | 1,009.60 | 1,030.50 | 5,995 |
| 2026-04-29 | 1,052.00 | 1,056.50 | 1,025.20 | 1,033.05 | 6,959 |
| 2026-04-28 | 987.50 | 1,059.90 | 982.25 | 1,050.85 | 44,741 |
| 2026-04-27 | 962.00 | 984.95 | 950.50 | 977.70 | 12,624 |
| 2026-04-24 | 986.05 | 1,004.00 | 950.00 | 962.00 | 11,164 |
| 2026-04-23 | 980.65 | 997.35 | 975.55 | 985.45 | 3,005 |
| 2026-04-22 | 999.95 | 999.95 | 976.10 | 989.85 | 8,133 |
| 2026-04-21 | 999.80 | 1,019.95 | 971.20 | 988.90 | 10,699 |
| 2026-04-20 | 991.00 | 1,005.85 | 991.00 | 995.45 | 4,123 |
Novartis India Ltd. (NOVARTIND) is a subsidiary of the global pharmaceutical giant Novartis, specializing in the trading and wholesale distribution of pharmaceutical products within India. It operates independently to serve the domestic market, leveraging its parent company's global expertise while maintaining a shielded operational structure that avoids direct exposure to regional geopolitical risks. Incorporated on December 13, 1947, the company has established itself as a key player in the Indian healthcare sector, focusing on providing essential medicines and maintaining a strong market presence through its specialized focus and strategic alignment with international standards.